A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2010-09-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of PF-04447943 compared to placebo on
cognitive, behavioral and overall symptoms of Alzheimer's disease; evaluate the safety and
tolerability of PF-0444793 compared to placebo; and determine the levels of PF-04447943 in
the plasma over the course of the study.